Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.

Ryzhakov G, Almuttaqi H, Corbin AL, Berthold DL, Khoyratty T, Eames HL, Bullers S, Pearson C, Ai Z, Zec K, Bonham S, Fischer R, Jostins-Dean L, Travis SPL, Kessler BM, Udalova IA

Open source

DOI
10.1038/s41467-021-27038-5
Published
2021 Nov 18
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-021-27038-5,
  title = {Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.},
  author = {Ryzhakov G and Almuttaqi H and Corbin AL and Berthold DL and Khoyratty T and Eames HL and Bullers S and Pearson C and Ai Z and Zec K and Bonham S and Fischer R and Jostins-Dean L and Travis SPL and Kessler BM and Udalova IA},
  year = {2021},
  journal = {Nature communications},
  doi = {10.1038/s41467-021-27038-5},
  url = {https://doi.org/10.1038/s41467-021-27038-5}
}

RIS

TY  - JOUR
TI  - Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.
AU  - Ryzhakov G
AU  - Almuttaqi H
AU  - Corbin AL
AU  - Berthold DL
AU  - Khoyratty T
AU  - Eames HL
AU  - Bullers S
AU  - Pearson C
AU  - Ai Z
AU  - Zec K
AU  - Bonham S
AU  - Fischer R
AU  - Jostins-Dean L
AU  - Travis SPL
AU  - Kessler BM
AU  - Udalova IA
PY  - 2021
JO  - Nature communications
DO  - 10.1038/s41467-021-27038-5
UR  - https://doi.org/10.1038/s41467-021-27038-5
ER  - 

APA

G, R., H, A., AL, C., DL, B., T, K., HL, E., S, B., C, P., Z, A., K, Z., S, B., R, F., L, J., SPL, T., BM, K., & IA, U. (2021). Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation.. Nature communications. https://doi.org/10.1038/s41467-021-27038-5

Source records